CELEX: 32021M10143
Language: en
Date: 2021-04-14 00:00:00
Title: Commission Decision of 14/04/2021 declaring a concentration to be compatible with the common market (Case No COMP/M.10143 - INTER-RISCO / UNAVETS / ONEVET) according to Council Regulation (EC) No 139/2004 (Only the English text is authentic)

EUROPEAN COMMISSION
                                                                Brussels, 14.4.2021
                                                                C(2021) 2686 final
                                                                                 PUBLIC VERSION
                                                                Inter-Risco - Sociedade De Capital De
                                                                Risco, S.A
                                                                Rua Sá da Bandeira, no. 481,
                                                                2nd floor, right side
                                                                4000-436 – Porto
                                                                Portugal
                                                                Unavets Healthcare SL
                                                                Paseo de la Castellana 77
                                                                28046 – Madrid
                                                                Spain
Subject:        Case M.10143 – INTER-RISCO / UNAVETS / ONEVET
                Commission decision pursuant to Article 6(1)(b) of Council Regulation
                                       1
                (EC) No 139/2004 and Article 57 of the Agreement on the European
                                    2
                Economic Area
Dear Sir or Madam,
1.      On 17 March 2021, the European Commission received notification of a proposed
        concentration pursuant to Article 4 of the Merger Regulation by which Inter-Risco
        Sociedade de Capital de Risco, S.A. (“Inter-Risco”, Portugal), ultimately controlled
        by CaixaBank (Spain), and Unavets Healthcare, S.L. (“Unavets”, Spain), ultimately
        controlled by Oaktree Group (USA), acquire within the meaning of Article 3(1)(b)
        and 3(4) of the Merger Regulation joint control of the whole of OneVet Group, SGPS,
        S.A (“OneVet”, Portugal) currently controlled by Inter-Risco, by way of purchase of
        shares.3
2.      The business activities of the undertakings concerned are:
        −     for Inter-Risco: private equity firm established in Portugal with interests in the
              hospitality, engineering and construction sector, as well as in the supply of
1       OJ L 24, 29.1.2004, p. 1 (the ‘Merger Regulation’). With effect from 1 December 2009, the Treaty on
        the Functioning of the European Union (‘TFEU’) has introduced certain changes, such as the
        replacement of ‘Community’ by ‘Union’ and ‘common market’ by ‘internal market’. The terminology
        of the TFEU will be used throughout this decision.
2       OJ L 1, 3.1.1994, p. 3 (the ‘EEA Agreement’).
3       Publication in the Official Journal of the European Union No C 103, 25.3.2021, p. 16.
Commission européenne, DG COMP MERGER REGISTRY, 1049 Bruxelles, BELGIQUE
Europese Commissie, DG COMP MERGER REGISTRY, 1049 Brussel, BELGIË
Tel: +32 229-91111. Fax: +32 229-64301. E-mail: COMP-MERGER-REGISTRY@ec.europa.eu.
 ---pagebreak---         medical-veterinary services        (through    OneVet)  and   the roasting    and
        commercialisation of coffee,
   −    for Unavets: veterinary services group active in the supply of medical-veterinary
        services and ancillary activities in Spain,
   −    for OneVet: veterinary services group active in the supply of medical-veterinary
        services and ancillary activities in Portugal.
3. After examination of the notification, the European Commission has concluded that
   the notified operation falls within the scope of the Merger Regulation and of
   paragraph 5(b) of the Commission Notice on a simplified procedure for treatment of
   certain concentrations under Council Regulation (EC) No 139/2004.4
4. For the reasons set out in the Notice on a simplified procedure, the European
   Commission has decided not to oppose the notified operation and to declare it
   compatible with the internal market and with the EEA Agreement. This decision is
   adopted in application of Article 6(1)(b) of the Merger Regulation and Article 57 of
   the EEA Agreement.
                                                     For the Commission
                                                     (Signed)
                                                     Olivier GUERSENT
                                                     Director-General
4  OJ C 366, 14.12.2013, p. 5.
                                                 3